Persistence of specific humoral and cellular immunity in children after SARS-CoV-2 infection
Persistence of specific humoral and cellular immunity in children after SARS-CoV-2 infection

Persistence of specific humoral and cellular immunity in children after SARS-CoV-2 infection

Identidade Financiadora Merck Sharp & Dohme, Lda

Valor Financiado 67.400,00€

Consórcio Hospital D. Estefânia - CHULC

Data de Início 2020-01-01

Data de Fim 2023-01-01

Paulo Paixão

Investigador Principal

Quer saber mais sobre este projeto?